About
Gedea Biotech develops pHyph, an antibiotic-free, CE-marked vaginal treatment for bacterial vaginosis that restores and strengthens the vaginal microbiome, conducting clinical trials and preparing for commercialization.
Explore Gedea Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.